medical technology News
-
BYTEC CEO again on the Board of the VDMA Working Group Medical Technology
The board election of the VDMA Medical Technology Working Group is over. All candidates standing for election - including our CEO Paul W. Coenen - were confirmed. The new board for the election period 2021 - 2025 thus starts its work. The purpose of the VDMA Working Group Medical Technology is to provide a platform for exchange in the field of production in medical technology, to represent and ...
-
Showcase
RTsafe and Biomedic Medical Group sign exclusive agreement for distribution
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that Biomedic Medical Group will be the exclusive distributor of RTsafe’s products in China. We are delighted to announce this new collaboration and looking forward to provide our products to the Chinese radiotherapy professionals. ...
By RTsafe
-
Quantified Biology at Medtech
It was an exciting meeting at Medtech – NYC Medical Technology Forum, and a pleasure to ...
-
OtoNexus Medical Technologies and Fraunhofer IPMS Partnership
OtoNexus is pleased to announce our partnership with Fraunhofer IPMS (Dresden, Germany) to continue the development of our ultrasound transducers. ...
-
PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced a procedural update on its settlement of a previously disclosed class action ...
By PAVmed Inc.
-
Scion Medical Technologies Receives CE Mark Clearance for Cassi Breast Biopsy System
Newton, MA– Scion Medical Technologies, LLC. has received CE Mark (Conformité Européenne) designation for the Cassi breast biopsy system. The CE Mark paves the way for the Cassi breast biopsy system to be offered to the European market. About Scion Medical Technologies Scion Medical Technologies (Scion) is a global medical device company with US headquarters in ...
-
Creative Medical Technology to Participate in the 34th Annual Roth Conference
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that Company executives will be participating in the 34th Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. ...
-
Outset Medical to Present at SVB Leerink Global Healthcare Conference
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Friday, February 18, 2022 at 12:40pm PT / 3:40pm ET. A live and archived webcast ...
-
Outset Medical to Present at 42nd Annual Cowen Health Care Conference
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET. A live and archived webcast of the ...
-
Scion Medical Technologies Receives ISO 13485 Certification
Newton, MA– Scion Medical Limited was awarded ISO 13485 certification both for its China manufacturing facility in Taizhou, China and for its US subsidiary, Scion Medical Technologies LLC. ISO 13485 is an internationally recognized quality standard for medical devices. ISO 13485 represents the requirements for a comprehensive quality management system for the design and manufacture of ...
-
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective April 4, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies ...
-
NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective March 1, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies ...
-
cion Hosts Symposium: Medical Devices in the Emerging Chinese Market
November 21, 2011 – Waltham, Massachusetts. Scion Medical Technologies co-hosted the symposium, “Medical Devices in the Emerging Chinese Market”. Scion and its co-host, CMC Group, the investment arm of China Medical City, a government backed life sciences economic zone in Taizhou, China, brought together a panel of leading medical device industry experts from the U.S. and China ...
-
AxioSonic selected as MedTech Innovator 50 Leading Startups for 2018 Showcase and Accelerator.
MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, announced that AxioSonic was selected as one of 50 companies to participate in the organization’s four-month 2018 program, featuring the industry’s most promising medical technologies from around the globe. The 2018 cohort features 25 early-stage and 25 mid-stage companies with ...
-
Vestech Sponsors MedTech’s Got Talent
In its 5th year, MedTech’s Got Talent is Australia’s largest medical device accelerator program. The program is a unique entrepreneurship challenge which supports emerging entrepreneurs to develop and refine skills in pitching a business concept, developing a technology roadmap, and launching commercialisation activities for their medical technology innovations. There is no charge to ...
-
Cerevast Licenses Ultrasound Neuromodulation Technologies from Arizona State University for Post-Stroke Rehabilitation
Cerevast Medical, Inc., a medical technology company that develops medical products for the treatment of neurologic disorders, has licensed several technologies from Arizona State University to be used in innovative post-stroke rehabilitation ...
-
NeuroOne to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ET
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will host a conference call to discuss recent disclosures tomorrow, March 29, 2022, at 10:00 am Eastern Time. The purpose of the call is to provide ...
-
2016 bi- annual meeting in Guiyang Guizhou
On 15th July, Huacheng Medical Technology Co., Ltd grandly held its bi-annual meeting in Guiyang city, Guizhou Province. The General manager, manufacturing department, technology department, quality control department, sales department as well as the office support staff, 30 staff in total, have all participated in this meeting. The manager of the technology department spoke at the meeting and ...
-
Scion Acquires Soft Tissue Marker with FDA Marketing Clearance from Kent Medical Devices, Inc.
June 26, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired a soft tissue marker product line with FDA marketing clearance from Kent Medical Devices, Inc. of Minneapolis, Minnesota. “The Kent Medical Devices soft tissue marker product line bolsters our ...
-
Beta Bionics Receives FDA Breakthrough Device Designation for the iLet Bionic Pancreas System
Boston, MA -July 1, 2019 - Beta Bionics, Inc. — a medical technology company leveraging lifelong autonomous learning to develop and commercialize the world's first fully automated bionic pancreas — today announced that the company has completed a S63 million Series B2 equity financing. This follows six months after the final close of another $63 million equity financing and brings the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you